Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96646017 | 9664601 | 7 | F | 20130107 | 20160801 | 20131101 | 20160809 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-17272931 | BRISTOL MYERS SQUIBB | 13.25 | YR | M | Y | 0.00000 | 20160809 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96646017 | 9664601 | 1 | SS | DASATINIB | DASATINIB | 1 | Unknown | Y | 0 | FILM-COATED TABLET | |||||||||
| 96646017 | 9664601 | 2 | PS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | UNK | Y | 18768 | SOLUTION FOR INJECTION/INFUSION | ||||||||
| 96646017 | 9664601 | 3 | C | ARA-C | CYTARABINE | 1 | Intravenous (not otherwise specified) | 5 G, QD | Y | 0 | 5 | G | QD | ||||||
| 96646017 | 9664601 | 4 | C | PEG-L-ASPARAGINASE | PEGASPARGASE | 1 | Intravenous (not otherwise specified) | 3175 MG, UNK | Y | 0 | 3175 | MG | |||||||
| 96646017 | 9664601 | 5 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96646017 | 9664601 | 1 | Acute lymphocytic leukaemia |
| 96646017 | 9664601 | 2 | Acute lymphocytic leukaemia |
| 96646017 | 9664601 | 3 | Acute lymphocytic leukaemia |
| 96646017 | 9664601 | 4 | Acute lymphocytic leukaemia |
| 96646017 | 9664601 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96646017 | 9664601 | HO |
| 96646017 | 9664601 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96646017 | 9664601 | Ascites | |
| 96646017 | 9664601 | Clostridium difficile infection | |
| 96646017 | 9664601 | Device related infection | |
| 96646017 | 9664601 | Diarrhoea | |
| 96646017 | 9664601 | Haemothorax | |
| 96646017 | 9664601 | Hypoalbuminaemia | |
| 96646017 | 9664601 | Neutropenia | |
| 96646017 | 9664601 | Pleural effusion | |
| 96646017 | 9664601 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96646017 | 9664601 | 2 | 20130102 | 20130104 | 0 | |
| 96646017 | 9664601 | 3 | 20121231 | 20130102 | 0 | |
| 96646017 | 9664601 | 4 | 20130105 | 20130105 | 0 | |
| 96646017 | 9664601 | 5 | 20121231 | 20130104 | 0 |